NCT02312622 Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01991678 A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol) Status COMPLETED Phase PHASE1
NCT01976143 A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety Status COMPLETED Phase PHASE1
NCT01876446 Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01799993 Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia Status COMPLETED Phase PHASE3
NCT01663012 Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma Status COMPLETED Phase PHASE2
NCT01619839 A Phase 2 Study To Assess The Efficacy, Tolerability, And Safety OF NKTR-181 In Subjects With Chronic OA Knee Pain Status COMPLETED Phase PHASE2
NCT01457118 An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies Status COMPLETED Phase PHASE2
NCT01021436 Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia Status COMPLETED Phase PHASE2
NCT01004445 A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS) Status COMPLETED Phase PHASE2
NCT00856375 NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00806156 Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00802945 Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00600119 A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC) Status COMPLETED Phase PHASE2
NCT00598975 NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b) Status COMPLETED Phase PHASE2
NCT00396578 Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilation Status COMPLETED Phase PHASE2
NCT00370565 Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy. Status COMPLETED Phase PHASE3
NCT00123201 Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache Status COMPLETED Phase PHASE2